These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6708516)
21. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers. Kawamura I; Mizota T; Lacey E; Tanaka Y; Manda T; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Uht RM; Anderson CM; Webb P; Kushner PJ Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234 [TBL] [Abstract][Full Text] [Related]
23. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Bursch W; Ellinger A; Kienzl H; Török L; Pandey S; Sikorska M; Walker R; Hermann RS Carcinogenesis; 1996 Aug; 17(8):1595-607. PubMed ID: 8761415 [TBL] [Abstract][Full Text] [Related]
24. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Nomura Y; Tashiro H; Takaeko F Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351 [TBL] [Abstract][Full Text] [Related]
25. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells. Lamberts SW; van Koetsveld P; Verleun T Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432 [TBL] [Abstract][Full Text] [Related]
26. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352 [TBL] [Abstract][Full Text] [Related]
27. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen. Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064 [TBL] [Abstract][Full Text] [Related]
28. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy]. Kameda H Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840 [TBL] [Abstract][Full Text] [Related]
29. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079 [TBL] [Abstract][Full Text] [Related]
30. Progesterone and dexamethasone inhibition of estrogen-induced synthesis of DNA and complement in rat uterine epithelium: effects of antiprogesterone compounds. Bigsby RM J Steroid Biochem Mol Biol; 1993 Apr; 45(4):295-301. PubMed ID: 8499337 [TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Taylor CM; Blanchard B; Zava DT Cancer Res; 1984 Apr; 44(4):1409-14. PubMed ID: 6704959 [TBL] [Abstract][Full Text] [Related]
32. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus. Lyman SD; Jordan VC Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716 [TBL] [Abstract][Full Text] [Related]
33. Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers. Müller-Holzner E; Marth C; Zeimet AG; Hofstädter F; Daxenbichler G J Steroid Biochem Mol Biol; 1996 Apr; 58(1):13-9. PubMed ID: 8809182 [TBL] [Abstract][Full Text] [Related]
34. Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Zhou F; Bouillard B; Pharaboz-Joly MO; André J Mol Cell Endocrinol; 1989 Oct; 66(2):189-97. PubMed ID: 2612731 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999 [TBL] [Abstract][Full Text] [Related]
36. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site. Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333 [TBL] [Abstract][Full Text] [Related]
37. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148 [TBL] [Abstract][Full Text] [Related]
38. Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1. Dietel M; Löser R; Röhlke P; Jonat W; Niendorf A; Gerding D; Kohr A; Hölzel F; Arps H J Cancer Res Clin Oncol; 1989; 115(1):36-40. PubMed ID: 2921271 [TBL] [Abstract][Full Text] [Related]
39. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
40. Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Malet C; Gompel A; Spritzer P; Bricout N; Yaneva H; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P Cancer Res; 1988 Dec; 48(24 Pt 1):7193-9. PubMed ID: 3056610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]